(Journal Article): Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
 
Meier JJ, Hucking K, Holst JJ, Deacon CF, Schmiegel WH, Nauck MA
 
IN: Diabetes 2001; 50:2497-2504
Impact Factor(s) of Diabetes: 8.848 (2004), 8.298 (2003), 8.256 (2002), 7.7 (2001)

ABSTRACT: In patients with type 2 diabetes, gastric inhibitory polypeptide (GIP) has lost much of its insulinotropic activity. Whether this is similar in first-degree relatives of patients w... Click HERE for details